Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 79 Records) |
| Query Trace: Lung Neoplasms and ATM[original query] |
|---|
| Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 9 15 (12): 1871-1879. Esai Selvan Myvizhi, Zauderer Marjorie G, Rudin Charles M, Jones Siân, Mukherjee Semanti, Offit Kenneth, Onel Kenan, Rennert Gad, Velculescu Victor E, Lipkin Steven M, Klein Robert J, Gümü? Zeynep |
| The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility. Translational lung cancer research 2020 7 9 (3): 646-658. Liu Mengyuan, Liu Xinyi, Suo Peisu, Gong Yuan, Qu Baolin, Peng Xiumei, Xiao Wenhua, Li Yuemin, Chen Yan, Zeng Zhen, Lu Yinying, Huang Tanxiao, Zhao Yingshen, Liu Ming, Li Lifeng, Chen Yaru, Zhou Yanqing, Liu Guifeng, Yao Jianfei, Chen Shifu, Song Le |
| High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib. JTO clinical and research reports 2021 9 2 (7): 100191. Osoegawa Atsushi, Yamaguchi Masafumi, Nakamura Tomomi, Morinaga Ryotaro, Tanaka Kentaro, Kashiwabara Kosuke, Miura Takashi, Suetsugu Takayuki, Harada Taishi, Asoh Tatsuma, Taguchi Kenichi, Nabeshima Kazuki, Kishimoto Junji, Sakai Kazuko, Nishio Kazuto, Sugio Ken |
| The most frequent Polish ATM mutations are not susceptibility factors for tobacco-related cancers. Archives of medical science : AMS 2021 9 17 (5): 1158-1163. Podralska Marta, Dzikiewicz-Krawczyk Agnieszka, Mosor Maria, ?urawek Magdalena, I?ykowska Katarzyna, S?omski Ryszard, Rydzanicz Ma?gorzata, Gabryel Piotr, Dyszkiewicz Wojciech, Zió?kowska-Suchanek Iwo |
| Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung. Cell death & disease 2021 May 12 (5): 472. Song Zhengbo, Liu Yueping, Cheng Guoping, Chang Lianpeng, Yu Zicheng, Chen Ming, Chen Ga |
| Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G. Clinical lung cancer 2021 2 22 (3): 187-194.e1. Owonikoko Taofeek K, Redman Mary W, Byers Lauren A, Hirsch Fred R, Mack Philip C, Schwartz Lawrence H, Bradley Jeffrey D, Stinchcombe Thomas E, Leighl Natasha B, Al Baghdadi Tareq, Lara Primo, Miao Jieling, Kelly Karen, Ramalingam Suresh S, Herbst Roy S, Papadimitrakopoulou Vassiliki, Gandara David |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sönke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers. British journal of haematology 2022 8 199 (3): 371-381. Petrackova Anna, Savara Jakub, Turcsanyi Peter, Gajdos Petr, Papajik Tomas, Kriegova E |
| Rare germline deleterious variants increase susceptibility for lung cancer. Human molecular genetics 2022 Jun . Sang Jian, Zhang Tongwu, Kim Jung, Li Mengying, Pesatori Angela C, Consonni Dario, Song Lei, Liu Jia, Zhao Wei, Hoang Phuc H, Campbell Dave S, Feng James, D'Arcy Monica E, Synnott Naoise, Chen Yingxi, Wu Zeni, Zhu Bin, Yang Xiaohong R, Brown Kevin M, Choi Jiyeon, Shi Jianxin, Landi Maria Tere |
| Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 4 31 (7): 1450-1459. Mukherjee Semanti, Bandlamudi Chaitanya, Hellmann Matthew D, Kemel Yelena, Drill Esther, Rizvi Hira, Tkachuk Kaitlyn, Khurram Aliya, Walsh Michael F, Zauderer Marjorie G, Mandelker Diana, Topka Sabine, Zehir Ahmet, Srinivasan Preethi, Esai Selvan Myvizhi, Carlo Maria I, Cadoo Karen A, Latham Alicia, Hamilton Jada G, Liu Ying L, Lipkin Steven M, Belhadj Sami, Bond Gareth L, Gümü? Zeynep H, Klein Robert J, Ladanyi Marc, Solit David B, Robson Mark E, Jones David R, Kris Mark G, Vijai Joseph, Stadler Zsofia K, Amos Christopher I, Taylor Barry S, Berger Michael F, Rudin Charles M, Offit Kenne |
| Mutational status of main driver genes influences the prognosis of stage I-III lung adenocarcinoma patients underwent radical surgery. Translational cancer research 2021 Jul 10 (7): 3286-3298. Liao Hongliang, Luo Xiaoyan, Liang Yaqin, Wan Renping, Xu Me |
| PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study. BMC cancer 2022 Oct 22 (1): 1066. Kojima Kensuke, Imai Saki, Samejima Hironobu, Fujiwara Ayako, Tokunaga Toshiteru, Yoon Hyungeun, Okishio Kyoic |
| Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS-Mutated Non-Small-Cell Lung Cancer. JCO precision oncology 2022 1 5 153-162. Padda Sukhmani K, Aredo Jacqueline V, Vali Shireen, Singh Neeraj K, Vasista Sumanth M, Kumar Ansu, Neal Joel W, Abbasi Taher, Wakelee Heather |
| The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
| Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. Thoracic cancer 2023 9 . Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wa |
| Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients. Translational lung cancer research 2023 7 12 (6): 1236-1244. Ju-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, Jennifer J D Morrissette, Katherine L Nathanson, Roger B Cohen, Jason N Rosenba |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
| Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy. Frontiers in pharmacology 2023 3 14 1119837. Liu Jia-Si, Liu Jun-Yan, Xiao Qi, Li Xiang-Ping, Chen Juan, Liu Zhao-Qi |
| [Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 2 52 (2): 117-123. Guo L Y, Xiang C, Zhao R Y, Chen S N, Ma S J, Han Y |
| Association of Reported Candidate Monogenic Genes With Lung Cancer Risk. Clinical lung cancer 2023 2 . Rifkin Andrew S, Less Ethan M, Wei Jun, Shi Zhuqing, Zheng Siqun Lilly, Helfand Brian T, Hulick Peter J, Krantz Seth B, Xu Jianfe |
| The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. Journal of translational medicine 2023 12 21 (1): 874. Wei Wei, Fangfang Shi, Yang Xu, Yang Jiao, Ying Zhang, Qiuxiang Ou, Xue Wu, Lingyi Yang, Jinhuo L |
| Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
| Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing. Molecular oncology 2023 10 . Zhe Yu, Zirui Zhang, Jun Liu, Xiaoying Wu, Xiaojun Fan, Jiaohui Pang, Hua Bao, Jiani Yin, Xue Wu, Yang Shao, Zhengcheng Liu, Fang L |
| Ataxia telangiectasia-mutated rs56009889 and risk of common cancers. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2024 8 . Ofra Barnet-Griness, Stephen B Gruber, Steven M Lipkin, Katerina Shulman, Riad Haddad, Ronen Galili, Gad Renne |
| Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung). Journal of translational medicine 2024 7 22 (1): 714. Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, Pierfilippo Crucitti, Roberta Petti, Bruno Vincenzi, Giuseppe Tonini, Francesco M Venanzi, Alessandra Bulotta, Sara Oresti, Carlo Greco, Sara Ramella, Lucio Crinò, Angelo Delmonte, Roberto Ferrara, Massimo Di Maio, Fiorella Gurrieri, Alessio Cortelli |
| Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study. Lung cancer (Amsterdam, Netherlands) 2024 6 194 107864. Oscar Arrieta, Enrique Caballé-Pérez, Norma Hernández-Pedro, Eunice Romero-Nuñez, José Lucio-Lozada, Cesar Castillo-Ruiz, Karla Acevedo-Castillo, Rosa María Álvarez-Gómez, Carolina Molina-Garay, Marco Jiménez-Olivares, Karol Carrillo-Sánchez, Elvia Cristina Mendoza-Caamal, Andrés F Cardona, Jordi Remon, Carmen Alaez-Vers |
| DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis. Clinical oncology (Royal College of Radiologists (Great Britain)) 2024 4 . W S Yiu, T S M Chu, Y Meng, F-M Spring Ko |
| Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Frontiers in endocrinology 2024 10 15 1364021. Ariel R Choi, Ralph B D'Agostino, Michael K Farris, Mohammed Abdulhaleem, John C Hunting, Yuezhu Wang, Margaret R Smith, Jimmy Ruiz, Thomas W Lycan, W Jeffrey Petty, Christina K Cramer, Stephen B Tatter, Adrian W Laxton, Jaclyn J White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D Ch |
| Effects of Ataxia-Telangiectasia Mutated Variants on Radionecrosis and Local Control After Stereotactic Radiation Surgery for Non-Small Cell Lung Cancer Brain Metastases. Advances in radiation oncology 2024 1 9 (1): 101320. Warren Floyd, David Carpenter, Eugene Vaios, Rachel Shenker, Peter Hendrickson, Justus D Adamson, William M Giles, Chunhao Wang, Karen Allen, Trey Mullikin, Scott R Floyd, John P Kirkpatrick, Michelle Green, Zachary J Reitm |
| Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets. Journal of thoracic disease 2024 1 15 (12): 6796-6805. Wen Ouyang, Jing Yu, Zihang Zeng, Jun Gong, Junhong Zhang, Conghua X |
- Page last reviewed:Feb 1, 2024
- Content source: